Old Web
English
Sign In
Acemap
>
authorDetail
>
Nathan P. Horvat
Nathan P. Horvat
University of South Florida
Medicine
Myelofibrosis
Myeloproliferative neoplasm
Cancer research
context
4
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MPN-244: Comorbid Conditions Occur Frequently and Correlate with Early Disease Progression and Poor Outcomes in Young Patients with Myelofibrosis
2021
Clinical Lymphoma, Myeloma & Leukemia
Nathan P. Horvat
Rami S. Komrokji
Najla Al Ali
Chetasi Talati
Eric Padron
David A. Sallman
Kendra L. Sweet
Onyee Chan
Jeffrey E. Lancet
Andrew T. Kuykendall
Show All
Source
Cite
Save
Citations (0)
Outcomes of IDH1/2 mutant AML patients treated with IDH1/2 inhibitors: A single institutional experience.
2021
Journal of Clinical Oncology
Constantine Logothetis
Chetasi Talati
Gregoire Calon
Nathan P. Horvat
Virginia O. Volpe
Nicole D. Vincelette
Andrew T. Kuykendall
Onyee Chan
David A. Sallman
Eric Padron
Kendra L. Sweet
Rami S. Komrokji
Ling Zhang
Jeffrey E. Lancet
Seongseok Yun
Show All
Source
Cite
Save
Citations (0)
IBCL-247: Frontline Bendamustine and Rituximab in Extra-Nodal Marginal Zone Lymphoma: A Single-Institution Experience
2021
Clinical Lymphoma, Myeloma & Leukemia
Constantine Logothetis
Nathan P. Horvat
Tony Kurian
Celeste M. Bello
Julio C. Chavez
Leidy Isenalumhe
Bijal D. Shah
Lubomir Sokol
Hayder Saeed
Javier Pinilla
Sameh Gaballa
Show All
Source
Cite
Save
Citations (0)
Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis.
2020
Cancers
Andrew Kuykendall
Nathan P. Horvat
Garima Pandey
Rami S. Komrokji
Gary W. Reuther
Show All
Source
Cite
Save
Citations (6)
1